0001209191-23-058570.txt : 20231213 0001209191-23-058570.hdr.sgml : 20231213 20231213204945 ACCESSION NUMBER: 0001209191-23-058570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231211 FILED AS OF DATE: 20231213 DATE AS OF CHANGE: 20231213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xie Jian CENTRAL INDEX KEY: 0001819718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 231485381 MAIL ADDRESS: STREET 1: C/O FULGENT GENETICS, INC. STREET 2: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-11 0 0001674930 Fulgent Genetics, Inc. FLGT 0001819718 Xie Jian C/O FULGENT GENETICS, INC. 4399 SANTA ANITA AVENUE EL MONTE CA 91731 0 1 0 0 President and COO 0 Common Stock 2023-12-11 4 S 0 10000 26.3179 D 375124 D Common Stock 2023-12-11 4 S 0 12000 26.6895 D 363124 D Common Stock 220816 I By Trust The shares were sold in multiple transactions at prices ranging from $26.26 to $26.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold in multiple transactions at prices ranging from $26.61 to $26.92, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein. /s/ Paul Kim as Attorney-in-Fact 2023-12-13